1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Asia Pacific Infusion Pumps Market to 2027 - Regional Analysis and Forecasts By Type, By Application and End User, and Country

Asia Pacific Infusion Pumps Market to 2027 - Regional Analysis and Forecasts By Type, By Application and End User, and Country

  • June 2019
  • 169 pages
  • ID: 5794698
  • Format: PDF
  • By The Insight Partners

Summary

Table of Contents

Search Inside

The Asia Pacific infusion pumps market is expected to reach US$ 3,114.7 Mn in 2025 from US$ 1,943.5 Mn in 2018. The market is estimated to grow with a CAGR of 7.0% from 2019-2025.
The growth of the infusion pumps market is primarily attributed to the growing geriatric population and increasing rate of obesity.However, high cost of diabetes care devices and increasing prevalence of type 2 diabetes are likely to pose a negative impact on the market growth.

On the other hand, rising medical tourism in developing countries is likely to have a positive impact on the growth of the Asia Pacific infusion pumps market in the coming years.
Infusion pumps are widely used in geriatric population as it is an improved method to administer medication/ hormone/ nutrition and others.The number of ageing people with diabetes is increasing due to increased lifespan and the increased prevalence of diabetes in the geriatric population in the region and worldwide.

Infusion pump for diabetes provides more flexibility to the patient’s lifestyle while giving them greater control of the disease.The elderly population is defined as group of people aged 65 and over.

Population ageing is poised to become one of the most significant social transformations of the twenty-first century.Across the globe, the number of persons aged 80 or above is projected to triple by 2050.

The approximate population is around 137 million in 2017 which will reach up to 425 million in 2050. The value is expected to increase to 909 million in 2100, around seven times its value in 2017. With increase in the number of geriatric population, the prevalence of the chronic diseases has increased. Therefore, the demand of infusion pumps products are expected to increase in the forecast period.
In 2017, the volumetric pumps segment held a largest market share of 43.7% of the infusion pumps market, by type. The segment is anticipated to witness growth at a substantial rate of 7.3% during the forecast period. This segment is also expected to dominate the market in 2025 owing to its benefits of delivering monitored dosage of medications to the patient. They are being preferred highly in hospitals as they are able to deliver large amount of fluids or medications.
In 2017, the chemotherapy segment held a largest market share of 36.4% of the infusion pumps market, by application. The segment is anticipated to witness the fastest growth rate of 6.8% during the forecast period. This segment is also expected to dominate the market in 2025 owing to rising incidences of cancer and increases use of infusion pumps for the administration of medications, to the cancer patients. The pumps for chemotherapy can be used both for inpatient as well as outpatient settings, which makes it a preferable choice for cancer patients.
In 2017, the hospital & clinics segment held a largest market share of 47.5% of the infusion pumps market, by end user. The segment is anticipated to witness the fastest growth rate of 7.4% during the forecast period. This segment is also expected to dominate the market in 2025 owing to rise in the number of surgical procedures as well as reimbursement policies which make the admission process in hospitals a preferred choice.
Some of the major primary and secondary sources for infusion pumps included in the report are, Cancer Research Initiatives Foundation (CARIF), Centers for Disease Control and Prevention (CDC), Clinical Evaluation Report (CER), Food and Drug Administration (FDA), National Institute for Health and Care Excellence (NICE) and others.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Biopharmaceuticals Market - Growth, Trends, and Forecast (2019 - 2024)

Biopharmaceuticals Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 5000
  • August 2019

Market OverviewThe global biopharmaceuticals market was valued at USD 237,250.8 million in 2018, and is estimated to be valued at USD 388,997.3 million in 2024, witnessing a CAGR of 8.59%. The market growth ...

Cholera - Pipeline Review, H2 2019

Cholera - Pipeline Review, H2 2019

  • $ 2000
  • August 2019

Cholera - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Cholera - Pipeline Review, H2 2019, provides an overview of the Cholera (Infectious Disease) pipeline ...

Typhoid Fever - Pipeline Review, H2 2019

Typhoid Fever - Pipeline Review, H2 2019

  • $ 2000
  • August 2019

Typhoid Fever - Pipeline Review, H2 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Typhoid Fever - Pipeline Review, H2 2019, provides an overview of the ...

Plague - Pipeline Review, H2 2019 $ 2000 September 2019

Vaccines Markets in China $ 4000 July 2019


Download Unlimited Documents from Trusted Public Sources

Influenza Statistics and Vaccine Market in the US

  • October 2019
    32 pages
  • Infectious Dise...  

    Influenza  

    Vaccine  

  • United States  

    North America  

View report >

Vaccine Market and Influenza Statistics in the US

  • October 2019
    8 pages
  • Vaccine  

    Infectious Dise...  

    Influenza  

  • United States  

    North America  

View report >

Vaccine Market and Influenza Statistics in the US and India

  • October 2019
    6 pages
  • Vaccine  

    Influenza  

    Hospital  

  • United States  

    India  

View report >

ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on